Newamsterdam Pharma N V's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Newamsterdam Pharma N V (NAMS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Newamsterdam Pharma N V vs Its Competitors
- TTM: Trailing 12-month revenue of 7M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+107.9% annualized vs trailing 12 months).
- Scale: Newamsterdam Pharma N V ranks #80 of 544 companies by market capitalization in the Major Pharmaceutical Preparations industry, holding 0.1% of industry market cap.
- Peer revenue share: Newamsterdam Pharma N V accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
NAMS Sales vs. its Competitors, Q2 2026
Newamsterdam Pharma N V generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Major Pharmaceutical Preparations industry grew revenue 7.2% year over year, combined, vs -80.7% for Newamsterdam Pharma N V. Newamsterdam Pharma N V's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Newamsterdam Pharma N V's Competitor Quality Breadth
Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Newamsterdam Pharma Company N v | No | No | No | Yes |
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 12.50 % (1 of 8) | 12.50 % (1 of 8) | 12.50 % (1 of 8) | 62.50 % (5 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.